PGx Tools Will Help Pharmas Mitigate Economic, Regulatory Challenges, Tufts Report Predicts
 
Pharmaceutical companies this year will rely on pharmacogenomic technologies to offset rising drug-development costs, loss of patent exclusivity, and a tight reimbursement environment, according to the Tufts Center for the Study of Drug Development.
 
“Drug developers will work to validate safety and efficacy biomarkers, develop predictive preclinical toxicology screens, utilize micro-dosing studies, and expand

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.